Navigation Links
Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
Date:10/1/2008

proximately 8,000 individuals have received pramlintide in clinical trials, including more than 950 in obesity studies. Metreleptin (methionyl recombinant leptin; r-metHuLeptin) is an analog of human leptin, a neurohormone secreted by fat cells that plays a fundamental role in the regulation of energy metabolism and body weight. To date, more than 1,200 overweight or obese individuals have received metreleptin in clinical trials, several of which were 16 weeks or longer in duration.

Preclinical and clinical evidence published recently in PNAS, Proceedings of the National Academy of Sciences of the United States of America, demonstrates that, when pramlintide and metreleptin are administered in combination, leptin responsiveness is at least partially restored by amylin agonism. Experiments in diet-induced obese rats co-administrated with amylin and leptin resulted in synergistic reductions in food intake (up to 45%) and body weight (up to 15%), effects considerably greater than with leptin or amylin treatment alone. Weight loss with amylin/leptin treatment was fat- specific, and not accompanied by a reduction in lean mass. Translational clinical research confirms that findings in the non-clinical experiments are relevant to human obesity and suggest that metreleptin and pramlintide may be effective partners to pramlintide in the treatment of obesity. The most common side effects with the pramlintide/metreleptin combination treatment were injection site adverse events and nausea, which were mostly mild to moderate and transient in nature.

Important Safety Information for SYMLIN(R)

SYMLIN is not intended for all patients with diabetes. SYMLIN is used with insulin and has been associated with an increased risk of insulin-induced severe hypoglycemia, particularly in patients with type 1 diabetes. When severe hypoglycemia associated with SYMLIN use occurs, it is seen within three hours following a SYMLIN injection. If severe hypoglycemia occurs while
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
3. Critical Pharmaceuticals Enter Sustained Release hGH Arena
4. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
5. Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
6. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
7. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
8. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
9. QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
10. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
11. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... CARLSBAD, Calif. , June 30, 2015 /PRNewswire/ ... Inc. company (Nasdaq: NTK ) and a ... smart control markets, today announced it acquired mobile ... assets from privately held Numera, Inc. ... Numera creates best-in-class, easily implemented, mobile PERS products ...
(Date:6/30/2015)... June 30, 2015   Millar, Inc. , a ... announced the 2016 retirement of Craig Thummel , ... 12 years of service to the Company. The Company ... senior members of the Executive Management team as his ... Daugherty , currently Director of Sales and Marketing, as ...
(Date:6/30/2015)... Research and Markets( ... "Global Array Instruments Market 2015-2019" report ... instruments market to grow at a CAGR of ... global array instruments market can be divided into ... including tissue microarrays and cell microarrays. This report ...
Breaking Medicine Technology:Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 4Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 2
... Princeton HealthCare System (PHCS) ( www.princetonhcs.org ) will conduct its ... hosts a discussion about women,s pelvic floor disorders and treatment ... p.m. and can be joined by going to the PHCS ... has enormous potential for sharing information about health issues," said ...
... BEVERLY HILLS, Calif., Sept. 20 Waismann Method ... the first-ever National Take-Back Initiative, organized by the U.S. ... to encourage the public to surrender expired, unwanted or ... heels of recent reports that prescription drug abuse and ...
Cached Medicine Technology:First Live Web Chat by New Jersey's Princeton HealthCare System Focuses on Women's Health 2Waismann Method Supports National Take-Back Initiative 2Waismann Method Supports National Take-Back Initiative 3
(Date:6/30/2015)... ... ... Down is a reputable source of authentic Kid Rock tickets at the DTE Energy ... road again this summer in what is one of the most affordable summer tours in ... this year at the XFINITY Theatre in Hartford, CT on June 24th and the blockbuster ...
(Date:6/30/2015)... ... ... The American Institute of Personal Injury Attorneys (AIOPIA) awarded JTB Law Group, LLC as a ... Award respectively. As of July 1, 2015, the firm and Mr. Brown personally have ... Jersey. The award is a culmination of the hard work, long hours, and excellent ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... approved 40-hour Introduction to Hyperbaric Medicine Course. Clinicians from WCA partnering hospitals across ... medicine curriculum. , Wound care and hyperbaric medicine education and training is ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Trenton Health ... of the first Medicaid Accountable Care Organizations (ACO) in the State, serving the greater ... 1. , The Trenton Health Team ACO draws on the collaborative structure of THT, ...
(Date:6/30/2015)... San Diego, California (PRWEB) , ... June 30, 2015 , ... ... Sullivan Solar Power today at a media event in San Diego. Speakers and clean ... San Diego School of medicine, Natalie Germuska of Kindred Hospital, and Daniel Sullivan, founder ...
Breaking Medicine News(10 mins):Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2Health News:JTB Law Group, LLC Recognized as a Top 10 Best Law Firm by AIOPIA 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3
... , , ELMWOOD PARK, N.J. and ... its approximately 83% owned subsidiary, WebMD Health Corp. (Nasdaq: WBMD ), ... months ended June 30, 2009 at approximately 4:00 pm (ET) on Thursday, July ... on that day to discuss those results. , ...
... , ARDEE, Ireland, July 14 Warner Chilcott ... its second quarter 2009 financial results prior to the market opening on ... In addition to issuing a press release, the Company will host a ... 8:00 AM (Eastern Time) to review the results. To participate in the ...
... July 14 Earlier today a three judge panel of the ... a case considering the constitutionality of the 1995 Illinois Parental Notice of ... enjoined from enforcement until today,s ruling. The following statement can be attributed ... Illinois : , , ...
... ... Benjamin as President Obama,s pick for surgeon general. , ... Washington, DC (Vocus) June 14, 2009 --    U.S. ... surgeon general. The Alabama family physician has been an advocate for universal care, and ...
... , SAN FRANCISCO, July 14 ... Pfizer Inc. on its recently-completed divestment of three investigational compounds ... of the agreement were not disclosed. , ... Cholesterol-Aceyltransferase (ACAT) inhibitor currently in Phase 2 development for the ...
... , , SANTA MONICA, Calif., ... Dakim(R) BrainFitness(TM) System has now been adopted by 286 senior living communities ... memory loss. Dakim has added 136 new sites in the last year, ... the senior care market. , , ...
Cached Medicine News:Health News:HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call 2Health News:U.S. African Chamber Of Commerce Congratulates U.S. on New Surgeon General, May Improve Health Care for Middle Income Families 2Health News:U.S. African Chamber Of Commerce Congratulates U.S. on New Surgeon General, May Improve Health Care for Middle Income Families 3Health News:Burrill Merchant Banking Advises Pfizer Inc. on Dermatology Portfolio Divestment 2Health News:Dakim BrainFitness Now Used in 286 Senior Living Communities, Adding 136 Sites in 12 Months for Dementia-Fighting System 2Health News:Dakim BrainFitness Now Used in 286 Senior Living Communities, Adding 136 Sites in 12 Months for Dementia-Fighting System 3
Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
Epstein Curettes 3.0 mm, length 8" (203 mm)....
Cobb Spinal Curettes, tip size 13.00 mm, length 11" (279 mm)....
Karlin XL Magnum Ring Curettes, extra long (XL) curettes, black handles, lightweight. Length 13 1/4" (33.7 cm), handle length 8 1/2" (21 cm), handle diameter 1 1/4" (32 cm)....
Medicine Products: